- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.82 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1TI: 4-[(3S)-3-cyano-3-(1-methylcyclopropyl)-2-oxidanylidene-pyrrolidin-1-yl]-N-[[3-fluoranyl-5-(1-methylpyrazol-4-yl)phenyl]methyl]-6-methyl-pyridine-2-carboxamide(Non-covalent)
- 2 x HFG: 7-bromo-6-chloro-3-{3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3H)-one(Non-covalent)
HFG.2: 17 residues within 4Å:- Chain A: F.85, E.88, V.89, P.108, T.109, E.111, R.140, W.157, E.159, H.161, F.204, T.228, H.230, W.259, G.260
- Ligands: 1TI.1, BR.5
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:T.109, A:W.157, A:E.159, A:F.204
- Hydrogen bonds: A:T.109, A:R.140
- pi-Stacking: A:F.85, A:F.85
HFG.16: 17 residues within 4Å:- Chain B: E.88, V.89, P.108, T.109, E.111, R.140, W.157, E.159, H.161, F.204, T.228, H.230, S.258, W.259, G.260
- Ligands: 1TI.15, BR.18
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:P.108, B:T.109, B:W.157, B:E.159, B:F.204
- Hydrogen bonds: B:T.109, B:T.109, B:R.140
- Water bridges: B:R.140
- Halogen bonds: B:E.88
- 1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- 1 x BME: BETA-MERCAPTOETHANOL(Non-functional Binders)
- 6 x BR: BROMIDE ION(Non-covalent)(Non-functional Binders)
BR.5: 3 residues within 4Å:- Chain A: R.140
- Ligands: 1TI.1, HFG.2
Ligand excluded by PLIPBR.8: 3 residues within 4Å:- Chain A: F.12, N.220
- Ligands: IOD.10
Ligand excluded by PLIPBR.11: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPBR.18: 3 residues within 4Å:- Chain B: R.140
- Ligands: 1TI.15, HFG.16
Ligand excluded by PLIPBR.25: 3 residues within 4Å:- Chain B: E.300, N.301, T.302
Ligand excluded by PLIPBR.26: 3 residues within 4Å:- Chain B: K.47, C.188, R.284
Ligand excluded by PLIP- 10 x IOD: IODIDE ION(Non-functional Binders)
IOD.6: 1 residues within 4Å:- Chain A: P.471
Ligand excluded by PLIPIOD.7: 1 residues within 4Å:- Chain B: Y.28
Ligand excluded by PLIPIOD.9: 3 residues within 4Å:- Chain A: R.151, R.222, M.461
Ligand excluded by PLIPIOD.10: 2 residues within 4Å:- Chain A: Y.500
- Ligands: BR.8
Ligand excluded by PLIPIOD.14: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.19: 1 residues within 4Å:- Chain B: P.471
Ligand excluded by PLIPIOD.20: 2 residues within 4Å:- Chain B: K.298, Y.331
Ligand excluded by PLIPIOD.21: 2 residues within 4Å:- Chain B: R.324, R.328
Ligand excluded by PLIPIOD.22: 1 residues within 4Å:- Chain B: N.220
Ligand excluded by PLIPIOD.24: 7 residues within 4Å:- Chain B: L.296, N.301, T.302, G.303, E.304, I.305, L.306
Ligand excluded by PLIP- 3 x F: FLUORIDE ION(Non-covalent)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Malhotra, N. et al., TgPRS with double inhibitors. To Be Published
- Release Date
- 2022-07-06
- Peptides
- Prolyl-tRNA synthetase (ProRS): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.82 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1TI: 4-[(3S)-3-cyano-3-(1-methylcyclopropyl)-2-oxidanylidene-pyrrolidin-1-yl]-N-[[3-fluoranyl-5-(1-methylpyrazol-4-yl)phenyl]methyl]-6-methyl-pyridine-2-carboxamide(Non-covalent)
- 2 x HFG: 7-bromo-6-chloro-3-{3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3H)-one(Non-covalent)
- 1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- 1 x BME: BETA-MERCAPTOETHANOL(Non-functional Binders)
- 6 x BR: BROMIDE ION(Non-covalent)(Non-functional Binders)
- 10 x IOD: IODIDE ION(Non-functional Binders)
- 3 x F: FLUORIDE ION(Non-covalent)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Malhotra, N. et al., TgPRS with double inhibitors. To Be Published
- Release Date
- 2022-07-06
- Peptides
- Prolyl-tRNA synthetase (ProRS): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B